The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group
Abstract
Purpose: To develop a systematic review that would address the following question: Should patients with stage II colon cancer receive adjuvant therapy? Methods: A systematic review was undertaken to locate randomized controlled trials comparing adjuvant therapy to observation. Results: Thirty-seven trials and 11 meta-analyses were included. The evidence for stage II colon cancer comes primarily from a trial of fluorouracil plus levamisole and a meta-analysis of 1,016 patients comparing fluorouracil plus folinic acid versus observation. Neither detected an improvement in disease-free or overall survival for adjuvant therapy. A recent pooled analysis of data from seven trials observed a benefit for adjuvant therapy in a multivariate analysis for both disease-free and overall survival. The disease-free survival benefits appeared to extend to stage II patients; however, no P values were provided. A meta-analysis of chemotherapy by portal vein infusion has also shown a benefit in disease-free and overall survival for stage II patients. A meta-analysis was conducted using data on stage II patients where data were available (n = 4,187). The mortality risk ratio was 0.87 (95% CI, 0.75 to 1.01; P = .07). Conclusion: There is preliminary evidence indicating that adjuvant therapy is associated with a disease-free survival benefit for patients with stage II colon cancer. These benefits are small and not necessarily associated with improved overall survival. Patients should be made aware of these results and encouraged to participate in active clinical trials. Additional investigation of newer therapies and more mature data from the presently available trials should be pursued.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
(1995) · The Lancet · doi:10.1016/s0140-6736(95)90696-7 · Cited by 1,066
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Laurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., & Malliard, J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1447 · Cited by 700
O'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.246 · Cited by 585
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07186-4 · Cited by 504
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
(1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1356 · Cited by 444
Browman, G. P., Levine, M. N., Mohide, E. A., Hayward, R. S., Pritchard, K. I., Gafni, A., & Laupacis, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.502 · Cited by 440
Patterns of recurrence after curative resection of carcinoma of the colon and rectum.
Galandiuk, S., Wieand, H. S., Cg, M., Cha, S. S., Rj, F., Jh, P., & Wolff, B. G. (1992) · PubMed · Cited by 438
Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011
Wolmark, N., Fisher, B., Rockette, H., Redmond, C., Wickerham, D. L., Fisher, E. R., Jones, J., Glass, A., Lerner, H., Lawrence, W., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.30 · Cited by 400
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., & Glick, J. H. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.12.2936 · Cited by 369
Harris, J. E., Ryan, L., Hoover, H. C., Stuart, R. K., Oken, M. M., Benson, A. B., Mansour, E., Haller, D. G., Manola, J., & Hanna, M. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.148 · Cited by 273
Clinically useful measures of effect in binary analyses of randomized trials
Sinclair, J. C., & Bracken, M. B. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90191-0 · Cited by 270
Hoover, H. C., Brandhorst, J. S., Peters, L. C., Surdyke, M. G., Takeshita, Y., Madariaga, J., Muenz, L. R., & Hanna, M. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.390 · Cited by 259
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
Francini, G., Petrioli, R., Lorenzini, L., Mancini, S., Armenio, S., Tanzini, G., Marsili, S., Aquino, A., Marzocca, G., Civitelli, S., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90748-x · Cited by 241
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
on behalf of the NACCP group*, Taal, B. G., Van Tinteren, H., & Zoetmulder, F. A. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2117 · Cited by 218
Wolmark, N., Rockette, H., Wickerham, D. L., Fisher, B., Redmond, C., Fisher, E. R., Potvin, M., Davies, R. J., Jones, J., & Robidoux, A. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1466 · Cited by 211
FIELDING, L. P., Hittinger, R., Grace, R., & Fry, J. S. (1992) · The Lancet · doi:10.1016/0140-6736(92)91708-g · Cited by 136
Portal Vein Chemotherapy for Colorectal Cancer: a Meta-analysis of 4000 Patients in 10 Studies
Liver Infusion Meta-analysis Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.7.497 · Cited by 121
Should Dukes' B patients receive adjuvant therapy? A statistical perspective
Buyse, M. E., & Piedbois, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90247-7 · Cited by 109
Beart, R. W. (1990) · Archives of Surgery · doi:10.1001/archsurg.1990.01410190095015 · Cited by 108
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial
Rougier, P. R., Sahmoud, T., Nitti, D., Curran, D., Doci, R., Waele, B. D., Nakajima, T., Rauschecker, H., Labianca, R., Pector, J., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08169-5 · Cited by 84
Sakamoto, J., Hamada, C., Kodaira, S., Nakazato, H., & Ohashi, Y. (1999) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/29.2.78 · Cited by 63
Survival of Patients With Stage B2 Colon Carcinoma
Nauta, R. J. (1989) · Archives of Surgery · doi:10.1001/archsurg.1989.01410020050008 · Cited by 46
Nitti, D., Wils, J. A., Sahmoud, T., Curran, D., Couvreur, M. L., Lise, M., Rauschecker, H., dos Santos, J. G., Stremmel, W., & Roelofsen, F. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00052-x · Cited by 43
Adjuvant Therapy of Colorectal Cancer: Why We Still Don't Know
Buyse, M. (1988) · JAMA · doi:10.1001/jama.1988.03720240033031 · Cited by 18
Cited by
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Self-citationWeitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., & Büchler, M. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17706-x · Cited by 1,098
Metadata
- Authors
- Figueredo, A., Charette, M. L., Maroun, J., Brouwers, M. C., & Zuraw, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 3395-3407
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1976067359
- Cited by
- 348
- References
- 29
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.